ADAR1 Capital Management »

Arcturus Therapeutics Hldg I shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Arcturus Therapeutics Hldg I (ARCT) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Arcturus Therapeutics Hldg I

Tip: Access up to 7 years of quarterly data

All positions including Arcturus Therapeutics Hldg I held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcturus Therapeutics Hldg I by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $116k 15k 7.72

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Terns Pharmaceuticals Call Option (TERN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Zai Lab Adr (ZLAB)
Septerna (SEPN)
Vir Biotechnology (VIR)
Dbv Technologies S A Sponsored Ads (DBVT)

View all positions for ADAR1 Capital Management

Top funds holding Arcturus Therapeutics Hldg I

Federated Investors
ARK Investment Management
BlackRock
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Vanguard Group
Vanguard Capital Management
Two Sigma Investments
Vanguard Portfolio Management
Geode Capital Management
State Street Corporation
Millennium Management
UBS Group
Empire Life Investments
Dimensional Fund Advisors

View all funds holding Arcturus Therapeutics Hldg I